Abstract: An improved method for the treatment of intractable pain is provided by the present invention. The improved method is the intrathecal administration of a therapeutic composition comprising elcatonin and a pharmaceutically acceptable carrier. Intrathecally administered elcatonin produces more potent and prolonged analgesia than elcatonin/calcitonins administered by other routes (e.g., intravenous, intramuscular injection) and/or opiates administered by different routes (including epidural or intrathecal administration).
Type:
Grant
Filed:
April 18, 1995
Date of Patent:
February 24, 1998
Assignee:
Innapharma, Inc.
Inventors:
John Fowler Noble, Henry Baxter Abajian